doorway90

Sirtex Medical’s DOORwaY90 Study Demonstrates 100% Local Tumor Control with SIR-Spheres, Setting a New Benchmark in Y-90 for HCC

The DOORwaY90 study met its prespecified co-primary endpoints, achieving a best overall response rate (ORR) of 99%WOBURN, Mass., April 13,…

24 hours ago